Stocks / NASDAQ / Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical Inc.

Our Opinion

Ultragenyx Pharmaceutical is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical products, services, research and therapies.

Supporting Evidence:

Job Posting that specifies that the company conducts animal testing

“Animal handling experience, ability to dose rodents especially through intravenous drug administration besides PO, SC, IP, ICV injections; collect blood from rodents, perform necropsy tissues collections”



Company Description

Ultragenyx Pharmaceutical Inc., incorporated on June 13, 2011, is a clinical-stage biopharmaceutical company. The Company is focused on the identification, acquisition, development, and commercialization of products for the treatment of genetic diseases. The Company’s clinical-stage pipeline consists of two product categories: biologics (including a monoclonal antibody and an enzyme replacement therapy), and small-molecule substrate replacement therapies. [Source: Reuters]

Company Website: